Improvement in Glucose Regulation Using a Digital Tracker and Continuous Glucose Monitoring in Healthy Adults and Those with Type 2 Diabetes.

Ashkan Dehghani Zahedani¹, Solmaz Shariat Torbaghan¹, Salar Rahili¹, Kirill Karlin¹, Darrin Scilley¹, Riya Thakkar¹, Maziyar Saberi¹, Noosheen Hashemi¹, Dalia Perelman¹, Nima Aghaeepour¹, Tracey McLaughlin¹, Michael P Snyder²

¹January AI, 1259 El Camino Real #231, Menlo Park, CA, 94025, USA.

²January AI, 1259 El Camino Real #231, Menlo Park, CA, 94025, USA. mike@mail.january.ai.

PubMed PMC DOI PDF

Abstract

INTRODUCTION: While continuous glucose monitoring (CGM) has been shown to decrease both hyper- and hypoglycemia in insulin-treated diabetes, its value in non-insulin-treated type 2 diabetes (T2D) and prediabetes is unclear. Studies examining the reduction in hyperglycemia with the use of CGM in non-insulin-treated T2D are limited. METHODS: We investigated the potential benefit of CGM combined wit…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.